Randomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial

Protocol No

NRG-LU007

Staff Member

Jonathan Thompson

Phase

II/III

Summary

This study is being done to answer the following question: Can we extend the time without your extensive small cell lung cancer growing or spreading by adding radiation therapy to the usual treatment for this type of cancer (an immunotherapy drug called atezolizumab)?

We are doing this study because we want to find out if this approach is better or worse than the usual approach for your type of cancer. The usual approach is defined as care most people get for extensive stage small cell lung cancer.

Objective

Testing the addition of radiation therapy to the usual immune therapy treatment (atezolizumab) for patients with extensive stage small cell lung cancer

Study Sites

Froedtert West Bend Hospital Drexel Town Center Froedtert Menomonee Falls Hospital Froedtert Hospital

Status

OPEN TO ACCRUAL